Insights on Corporate & Securities
538 total results. Page 13 of 22.
On April 15, Congressional Bancshares, Inc. announced the successful closing of a $345 million private placement of its common stock.
On April 1, the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) issued an Advance Notice of Proposed Rulemaking (ANPRM) to solicit comments from the public on issues relevant to the implementation of the Corporate Transparency Act (CTA). The CTA was enacted into law as part of the National Defense Authorization Act for Fiscal Year 2021.
AgTech companies face an exciting opportunity to play a large role in achieving sustainability and promoting ESG.
Schiff Hardin LLP advised Maxim Group, LLC as underwriter in Model Performance Acquisition Corp.’s Nasdaq initial public offering of 5 million units at $10 per unit.
Schiff Hardin represented Altaris Capital Partners, LLC in the sale of Senior Helpers, an owner and franchisor of professional home care services designed to allow elderly individuals to stay in their homes as long as possible.
Arent Fox LLP has appointed Partner David M. Barbash to lead its Boston office as Managing Partner.
Schiff Hardin LLP acted as counsel to the placement agent in WiMi Hologram Cloud, Inc.’s registered direct offering of more than 11.1 million units at a purchase price of $7.50 per unit for a total offering size of approximately $83.8 million.
Schiff Hardin LLP acted as counsel to the placement agent in MingZhu Logistics Holdings Limited’s registered direct offering of an aggregate of more than 3.3 million units of its securities at a price of $6 per unit for aggregate gross proceeds of $20 million.
The Employee Retention Tax Credit (ERTC) has been expanded and extended further, providing relief to small and large employers affected by COVID-19 business disruptions. As we approach the one-year anniversary of its original enactment, employers should take a fresh look at their eligibility for the
Schiff represented Snap-on Incorporated in its approximately $200 million cash purchase of Dealer-FX Group, Inc., a leading developer, marketer, and provider of service operations software solutions for automotive original equipment manufacturer (OEM) customers and their dealers.
Schiff Hardin advised CNS Pharmaceuticals, Inc. in connection with its public offering of 5,750,000 shares of common stock and 2,875,000 warrants to purchase common stock for gross proceeds of $11.5 million.
Schiff Hardin advised Isleworth Healthcare Acquisition Corp. in connection with its initial public offering of 20,700,000 units at a price to the public of $10.00 per unit.
University of Richmond School of Law
Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in its agreement to acquire Perrigo Company plc’s prescription pharmaceuticals business (Rx) for $1.55 billion.
Each year, more than two million corporations, limited liability companies (LLCs), and other entities are formed in the United States. Historically, formation of these entities required little to no disclosure of their beneficial owners.
Schiff Hardin Partner Sarah A.W. Fitts has once again been recognized in the Chambers Global 2020 guide, which recognizes top lawyers and law firms in more than 200 jurisdictions across the world. Fitts earned her seventh consecutive ranking.
Schiff Hardin represented Washington Savings Bank on its acquisition of The First National Bank of Mattoon.
Schiff Hardin LLP acted as counsel to the placement agent in ZW Data Action Technologies, Inc.’s registered direct offering of more than 5.2 million shares of common stock at $3.59 per share and the concurrent private placement to the same investors of warrants to purchase up to 2,606,000 shares of common stock at an exercise price of $3.59 per share.
Schiff Hardin LLP advised Dawson James Securities, Inc. as underwriter in GT Biopharma, Inc.’s Nasdaq up-listing offering of 4.3 million units.
Schiff Hardin LLP acted as counsel to the placement agent in Senmiao Technology Limited’s registered direct offering of more than five million shares of common stock at $1.38 per share for aggregate gross proceeds of $7 million.
Schiff Hardin LLP acted as counsel to the placement agent in connection with CBAK Energy Technology, Inc.’s $70 million registered direct offering priced at-the-market under applicable Nasdaq rules.
Schiff Hardin LLP advised Moleculin Biotech, Inc. in connection with its public offering of 16,414,736 shares of common stock for gross proceeds of approximately $78 million.
Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in the majority recapitalization of Minnetronix Medical, Inc., a leading medical technology and operations partner to global medical device companies.